Cargando…
Alterations in DNA methylation/demethylation intermediates predict clinical outcome in chronic lymphocytic leukemia
Cytosine derivative dysregulations represent important epigenetic modifications whose impact on the clinical outcome in chronic lymphocytic leukemia (CLL) is incompletely understood. Hence, global levels of 5-methylcytosine (5-mCyt), 5-hydroxymethylcytosine (5-hmCyt), 5-carboxylcytosine (5-CaCyt) an...
Autores principales: | Bagacean, Cristina, Tempescul, Adrian, Le Dantec, Christelle, Bordron, Anne, Mohr, Audrey, Saad, Hussam, Olivier, Valerie, Zdrenghea, Mihnea, Cristea, Victor, Cartron, Pierre-François, Douet-Guilbert, Nathalie, Berthou, Christian, Renaudineau, Yves |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630365/ https://www.ncbi.nlm.nih.gov/pubmed/29029465 http://dx.doi.org/10.18632/oncotarget.20081 |
Ejemplares similares
-
Combining cytogenetic and epigenetic approaches in chronic lymphocytic leukemia improves prognosis prediction for patients with isolated 13q deletion
por: Bagacean, Cristina, et al.
Publicado: (2017) -
DNA demethylation marks in chronic lymphocytic leukemia: it is time to let the cat out of the bag
por: Bagacean, Cristina, et al.
Publicado: (2017) -
17p deletion strongly influences rituximab elimination in chronic lymphocytic leukemia
por: Bagacean, Cristina, et al.
Publicado: (2019) -
Rapid and complete response to idelalisib in a case of Richter syndrome
por: Bagacean, Cristina, et al.
Publicado: (2019) -
Resistance to complement activation, cell membrane hypersialylation and relapses in chronic lymphocytic leukemia patients treated with rituximab and chemotherapy
por: Bordron, Anne, et al.
Publicado: (2018)